McKesson (MIC:MCK-RM) Moat Score: 7/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is McKesson Moat Score?

McKesson MIC:MCK-RM 87 Moat Score is 7 as of Jul. 14, 2026. GuruFocus rates MIC:MCK-RM with a GF Score™ of 87/100. The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, McKesson ranks better than 99.16% on this metric.

McKesson has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

McKesson has Wide Moat: McKesson Corp has a wide moat due to its superior distribution network, economies of scale, and strong customer relationships in the healthcare distribution sector. These durable advantages provide significant pricing power and market leadership.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes McKesson might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

McKesson  (MIC:MCK-RM) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

McKesson Moat Score Related Terms

MIC:MCK-RM vs CAH, COR, HSIC: Moat Score Comparison

For the Medical Distribution subindustry, McKesson's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

McKesson Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson's Moat Score distribution charts can be found below:

* The bar in red indicates where McKesson's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
McKesson (MIC:MCK-RM) has a Moat Score of 7 as of Jul. 14, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, McKesson ranks #1 out of 119 companies in the Medical Distribution industry, placing it in the top 0.8%.
Is McKesson's Moat Score too high?
McKesson's current Moat Score is 7. Based on the distribution chart, McKesson ranks #1 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, McKesson has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does McKesson's Moat Score compare to CAH and COR?
According to the Medical Distribution industry distribution chart, McKesson ranks #1 out of 119 companies for Moat Score. This places McKesson in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. McKesson's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
McKesson (MIC:MCK-RM) has a current Moat Score of 7. The current Moat Score is 7. McKesson's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For McKesson (MIC:MCK-RM), the current Moat Score is 7 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.